Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
Phase 1 evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
Boucher FD, Modlin JF, Weller S, et al. Phase 1 evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus. J Pediatr 1993;122:137-44.
Chronic idiopathic intestinal pseudoobstruction: A commonly misdiagnosed disease in infants and children
Glassman M, Spivak W, Mininberg D, et al. Chronic idiopathic intestinal pseudoobstruction: a commonly misdiagnosed disease in infants and children. Pediatrics 1989;83:603-8.
Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine in human muscle in vitro and in an animal model
Lamperth L, Dalakas MC, Dagani F, et al. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine in human muscle in vitro and in an animal model. Lab Invest 1991;65:742-51.
Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: A report of six cases
Herskowitz A, Willoughby SB, Baughman KL, et al. Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases. Ann Intern Med 1992;116:311-3
Variation in mitochondrial DNa levels in muscle from normal controls: Is depletion of mtDNa in patients with mitochondrial myopathy a distinct clinical syndrome
Poulton J, Sewry C, Potter CG, et al. Variation in mitochondrial DNA levels in muscle from normal controls: is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome. J Inherit Metab Dis 1995;18:4-20.